2024 Technology Showcase

September 4, 2024 | 8:45 AM – 4:30 PM

Frederick National Laboratory Advanced Technology Research Facility Frederick, MD

2024 Technology Showcase, National Cancer Institute, Frederick National Laboratory

Update: If you are interested in learning more about any of the technologies or partnership opportunities highlighted at the 2024 Technology Showcase, please reach out to us at ncitechtransfer@mail.nih.gov.

The 2024 Technology Showcase is an event for potential and current industry partners that highlights how they can and do work with the NCI and the Frederick National Laboratory (FNL).

Keynote Speaker

Steven Walker, Chairman, Maryland Life Sciences — **Steven Walker**

Chairman

Maryland Life Sciences

Overview

September 4, 2024
Free, in-person event with networking and one-on-one partnering opportunities.
NCI and FNL inventors highlight technologies for commercialization and/or collaboration.
NCI and FNL programmatic leaders share opportunities to collaborate.
How to work with the NCI and the FNL, including the company perspective.
Panel sessions feature collaboration success stories and topics relevant to commercializing biomedical technology.
Technology Lightning Pitch followed by a Poster Presentation / Competition that highlights NIH technologies for co-development and/or licensing—presented by the NCI Technology Transfer Ambassadors Program.
Who should attend? Great opportunity for companies, investors, entrepreneurs, technology scouts seeking technologies to commercialize and all biotech stakeholders.

Meeting Partnering App

The 2024 Technology Showcase will utilize FLC Connect by Jujama, a conference partnering app. Attendees: please check your in-box for an email from Jujama with instructions on how to download the app. Once you have opted in and downloaded the app, you will be able to schedule partnering meetings, review the agenda and find everything you need about the event in one, convenient place.

Agenda

Speakers and session times to be posted as they become available.

Time	Session and Presenter
8:45 to 10:00 am	Onsite check-in; Coffee, One-on-One Partnering, Networking
10:00 to 10:15 am	Welcome Ethan Dmitrovsky, M.D., Director, Frederick National Laboratory for Cancer Research Michael O'Connor, Mayor, Frederick, MD Michael Salgaller, Ph.D., NCI Technology Transfer Center
10:15 to 11:00 am	Fireside Chat Moderator: Troy A. LeMaile-Stovall, CEO, TEDCO Guest: Helen Sabzevari, Ph.D., President & CEO, Precigen, Inc.
11:00 to 11:10 am	Voice of the Patient Katrece Nolen
11:10 to 11:35 am	Technology Presentations - Session 1 Moderator: Michael Pollack, Supervisory Technology Transfer Manager, NCI TTC "PIM-Targeted PROTACs" - E-094-2022 John Brognard, Ph.D., Senior Investigator, Laboratory of Cell and Developmental Signaling, CCR, NCI “Directed Acetylation of Cytidine in Cellular mRNA through Engineered snoRNA Adapters for the Treatment of Haploinsufficiencies” - E-017-2023 Shalini Oberdoerffer, Ph.D., Senior Investigator, Laboratory of Receptor of Biology and Gene Expression, CCR, NCI
11:35 to 11:50 am	Lightning Pitch Presented by participants in the 2024 NCI Technology Transfer Ambassadors Program (TTAP) Moderator: Suna Gulay-French, Ph.D., Technology Transfer Manager, TTC
11:50 am to 1:00 pm	Lunch, Poster Session / Competition, Networking, One-on-One Partnering Technology Posters “Small Molecule Eph Tyrosine Kinase Inhibitors for the Treatment of Colorectal Cancer” (E-182-2019); Poster Presenter, Daphna Fertil, TTAP Ambassador Technology Inventors: Giovanna Tosato, M.D., Senior Investigator, Laboratory of Cellular Oncology, NCI Center for Cancer Research (CCR); Michael Diprima, Ph.D., NCI CCR; Harald Schwalbe, Ph.D., JW Goethe University, Frankfurt; Alix Troster, Ph.D., JW Goethe University, Frankfurt; Nathalie Jores, M.S., JW Goethe University, Frankfurt; Denis Kudlinzki, Ph.D., German Cancer Research Center, DKFZ "Assay for Measuring and Quantifying DNA Damage" (E-276-2014) Poster presenter, Shiran Su, Ph.D. NCI TTC Technology Transfer CRTA Fellow Technology Inventors: Christophe Redon, Ph.D., Research Assistant, Developmental Therapeutics Branch, NCI CCR; Yiping Zhang, Ph.D., NCI, CCR; William Bonner, Ph.D. NCI CCR; Jiuping Ji, Ph.D., NCI CCR CAR T-cell Therapy Targeting Pediatric Neuroblastoma (E-025-2022) Poster presenter, Kiyoharu Joshua Miyagishima, Ph.D., TTAP Ambassador Technology Inventors: Mitchell Ho, Ph.D., Deputy Chief, Laboratory of Molecular Biology, NCI CCR; Carol Thiele Galetto, Ph.D., NCI CCR; Nan Li, Ph.D., NCI CCR; Rosa Nguyen, M.D., Ph.D., NCI CCR; Rosandra Kaplan, M.D., NCI CCR “Stealth” Lipid Nanoparticles for the Enhanced Delivery of Hydrophobic Agents (E-154-2018) Poster presenter, Julie Hixon, M.S., TTAP Ambassador Technology Inventors: Anu Puri, Ph.D., Program Director, NCI Center for Cancer Training; Mathias Viard, Ph.D., Senior Scientist, Laboratory of Integrative Cancer Immunology (NCI CCR) "Single Source-Detector Separation Approach to Calculate Tissue Oxygen Saturation" (E-037-2023) Poster presenter, Thien Nguyen, Ph.D., TTAP Ambassador Technology Inventors: Thien Nguyen, Ph.D. (NICHD); Soongho Park, Ph.D. (NICHD); Brian Hill (NICHD); Amir Gandjbakhche, Ph.D. (NICHD) "Bile Acids and Other Agents that Modulate the Gut Microbiome for the Treatment of Liver Cancer" (E-229-2017) Poster presenter, Yonghe Ma, Ph.D., TTAP Ambassador Technology Inventors: Tim Greten, M.D., Deputy Chief, Thoracic and GI Malignancies Branch, NCI CCR; Chi Ma, Ph.D. NCI CCR "3-o-sulfo-galactosylceramide Analogs Reduce Cancer Metastasis to the Lung" (E-100-2018) Poster presenter, Paul Suhwan Lee, TTAP Ambassador Technology Inventors: Lise Pasquet, Ph.D., NCI CCR; Jay Berzofsky, M.D., Ph.D., Chief, Vaccine Branch, NCI CCR; Amy Howell, Ph.D. University of Connecticut; Masaki Terabe, Ph.D. NCI CCR; Kaddy Camara, Ph.D. University of Connecticut "Engineering RNA Devices in Human T-cells to Control Gene Expression Externally"* (E-234-2023) Lead Inventor: Yun-Xing Wang, Ph.D., Senior Investigator, Center for Structural Biology, NCI CCR *Poster prepared by, Barbara Murphy, M.S., TTAP Ambassador (will not be presenting)
1:00 to 1:45 pm	Technology Presentations - Session 2 “Topoisomerase III (TOP3) Inhibitors and Antiviral Compounds based on Cyanine Dyes” - E-027-2022 Yves Pommier, M.D., Ph.D., Chief, Developmental Therapeutics Branch (DTB), Center for Cancer Research (CCR), NCI To be presented by: Shar-Yin Huang,Ph.D., Staff Scientist, DTB, CCR, NCI "Bioinformatics Pipelines," George Zaki, Ph.D. Director of Applied Scientific Computing, Biomedical and Computational Science Directorate, FNL "Advanced Preclinical Cancer Models" Serguei Kozlov, Ph.D., M.B.A., P.M.P., Principal Scientist, Center for Advanced Preclinical Research, FNL
1:45 to 1:50 pm	Announcement of Poster Session Winners
1:50 to 2:50 pm	FNL Programmatic Presentations Moderator: Maggie Scully, Ph.D., Director, Partnership Development Office CLIA Molecular Diagnostics Laboratory, Cancer Research Technology Program, FNL Kristen M. Pike, MS, PMP, Associate Scientist II, FNL Ryan Baugher, MS, PMP, QA Specialist, FNL HPV and COVID-19 Serology Laboratories: From the lab to public health impact Vaccine, Immunity, and Cancer Directorate, FNL Troy J. Kemp, Ph.D., Scientific Manager II, FNL Nanotechnology Characterization Laboratory, Cancer Research Technology Program, FNL Rachael Crist, Ph.D., Scientist, Head of Strategic Client Relations, FNL Molecular Characterization Laboratory, Clinical Research Program, FNL Bao Le, Ph.D., Scientist, FNL
2:50 to 3:30 pm	How to Work with the NCI and FNL Moderator: Steven Ferguson, MBA, Deputy Director Licensing and Entrepreneurship, NIH Office of Technology Transfer Amanda Corbel, Partnership Alliance Manager, Partnership Development Office, FNL Rose Freel, Ph.D., Supervisory Technology Transfer Manager, NCI TTC Andrew Sinkoe, Ph.D., Founder and CEO, Sesh, Inc. Xiaonao Liu, Ph.D. CEO, NanoBioFAB
3:30 to 4:00 pm	Keynote Presentation Steven Walker, Chairman, Maryland Life Sciences
4:00 to 4:45 pm	Dilutive and Non-Dilutive Sources of Support Moderator: Michael Salgaller, Ph.D., Technology Analysis and Marketing Unit Supervisor, NCI TTC Deborah Moorad, Ph.D., CEO, CorriXR Therapeutics Ruchika Nijhara, Ph.D., Executive Director, Maryland Stem Cell Research Fund David Speer, Executive Director, Maryland Israel Development Center Jess Miciak, Associate, American Cancer Society
4:45 pm	Thank you

The Technology Showcase will be followed by an independently sponsored networking event nearby with no resources from the Department of Health and Human Services.

Location

The Advanced Technology Research Facility at the Frederick National Laboratory
8560 Progress Drive
Frederick, MD 21701

Updated: September 5, 2024